Skip to main content

Advertisement

Log in

Immunohistochemical Expression of RAGE and Its Ligand (S100A9) in Cervical Lesions

  • Translational Biomedical Research
  • Published:
Cell Biochemistry and Biophysics Aims and scope Submit manuscript

Abstract

Altered expressions of receptor for advanced glycation end-products (RAGE) and its ligand (S100A9) are observed in many cancers and play a key role in inflammation-associated cancer. In our previous study, by two-dimensional gel electrophoresis followed by mass spectrometry, the expression of S100A9 protein was found to increase in squamous cervical cancer compared with adjacent normal cervical tissues. Therefore, in the present study we observed the expressions of S100A9 and RAGE in 30 chronic cervicitis, 50 cervical intraepithelial neoplasia (CIN), and 40 squamous cervical cancer (SCC) using immunohistochemical analysis and analyzed the differential expression and possible role of S100A9 and RAGE in cancer development. Immunohistochemical findings were as follows: the expressions of S100A9 and RAGE were demonstrated in chronic cervicitis, CIN, and SCC. Moreover, their expressions were gradually increasing as the tumor progressed. In SCC, the staining scores of S100A9 and RAGE were significantly higher in well-differentiated tumors compared to moderately and poorly differentiated tumors. The expression of S100A9 in epithelial cells exhibited a positive correlation to RAGE expression in chronic cervicitis, CIN, and SCC. There were no significant difference of S100A9 immunoreactivity in stromal cells among chronic cervicitis, CIN, and SCC. Moreover, there was no correlation between S100A9 immunoreactivity in stromal cells of SCC and clinicopathological parameters. Finally, double immunohistochemistry illustrated that RAGE and S100A9 co-express in SCC. In conclusion, RAGE binds its ligand (S100A9), which plays an important role in the development of SCC. In addition, the expressions of S100A9 and RAGE in SCC tumor cells were closely associated with histological differentiation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

RAGE:

Receptor for advanced glycation end products

CIN:

Cervical intraepithelial neoplasia

SCC:

Squamous cervical cancer

References

  1. Petignat, P., & Roy, M. (2007). Diagnosis and management of cervical cancer. BMJ, 335, 765–768.

    Article  PubMed  Google Scholar 

  2. Tiltman, A. J. (2005). The pathology of cervical tumours. Best Practice & Research Clinical Obstetrics & Gynaecology, 19, 485–500.

    Article  CAS  Google Scholar 

  3. Logsdon, C. D., Fuentes, M. K., Huang, E. H., et al. (2007). RAGE and RAGE ligands in cancer. Current Molecular Medicine, 7, 777–789.

    Article  PubMed  CAS  Google Scholar 

  4. Bucciarelli, L. G., Wendt, T., Rong, L., et al. (2002). RAGE is a multiligand receptor of the immunoglobulin superfamily: Implications for homeostasis and chronic disease. Cellular and Molecular Life Sciences, 59, 1117–1128.

    Article  PubMed  CAS  Google Scholar 

  5. Douqan, M., & Dranoff, G. (2008). Inciting inflammation: The RAGE about tumor promotion. Journal of Experimental Medicine, 205, 267–270.

    Article  Google Scholar 

  6. Hiwatashi, K., Ueno, S., Abeyama, K., et al. (2008). A novel function of the receptor for advanced glycation end-products (RAGE) in association with tumorigenesis and tumor differentiation of HCC. Annals of Surgical Oncology, 15, 923–933.

    Article  PubMed  Google Scholar 

  7. Hessian, P. A., Edgeworth, J., & Hogg, N. (1993). MRP-8 and MRP-14, two abundant Ca2+ binding proteins of neutrophils and monocytes. Journal of Leukocyte Biology, 53, 197–204.

    PubMed  CAS  Google Scholar 

  8. Gebhardt, C., Németh, J., Angel, P., et al. (2006). S100A8 and S100A9 in inflammation and cancer. Biochemical Pharmacology, 72, 1622–1631.

    Article  PubMed  CAS  Google Scholar 

  9. Chao, A., Wang, T. H., Lee, Y. S., et al. (2006). Molecular characterization of adenocarcinoma and squamous carcinoma of the uterine cervix using microarray analysis of gene expression. International Journal of Cancer, 119, 91–98.

    Article  CAS  Google Scholar 

  10. Zhu, X., Lv, J., Yu, L., et al. (2009). Proteomic identification of differentially-expressed proteins in squamous cervical cancer. Gynecologic Oncology, 112, 248–256.

    Article  PubMed  CAS  Google Scholar 

  11. Turovskaya, O., Foell, D., Sinha, P., et al. (2008). RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis. Carcinogenesis, 29, 2035–2043.

    Article  PubMed  CAS  Google Scholar 

  12. Hermani, A., Hess, J., De Servi, B., et al. (2005). Calcium-binding proteins S100A8 and S100A9 as novel diagnostic markers in human prostate cancer. Clinical Cancer Research, 11, 5146–5152.

    Article  PubMed  CAS  Google Scholar 

  13. Sasahira, T., Kirita, T., Bhawal, U. K., et al. (2007). Receptor for advanced glycation end products (RAGE) is important in the prediction of recurrence in human oral squamous cell carcinoma. Histopathology, 51, 166–172.

    Article  PubMed  CAS  Google Scholar 

  14. Arai, K., Teratani, T., Kuruto-Niwa, R., et al. (2004). S100A9 expression in invasive ductal carcinoma of the breast: S100A9 expression in adenocarcinoma is closely associated with poor tumour differentiation. European Journal of Cancer, 40, 1179–1187.

    Article  PubMed  CAS  Google Scholar 

  15. Moss, S. F., & Blaser, M. J. (2005). Mechanisms of disease: Inflammation and the origins of cancer. Nature Clinical Practice Oncology, 2, 90–97.

    Article  PubMed  CAS  Google Scholar 

  16. Huang, E. H., Park, J. C., Appelman, H., et al. (2006). Induction of inflammatory bowel disease accelerates adenoma formation in min ± mice. Surgery, 139, 782–788.

    Article  PubMed  Google Scholar 

  17. Bhawal, U. K., Ozaki, Y., Nishimura, M., et al. (2005). Association of expression of receptor for advanced glycation end products and invasive activity of oral squamous cell carcinoma. Oncology, 69, 246–255.

    Article  PubMed  CAS  Google Scholar 

  18. Sasahira, T., Kirita, T., Bhawal, U. K., et al. (2007). The expression of receptor for advanced glycation end products is associated with angiogenesis in human oral squamous cell carcinoma. Virchows Archiv, 450, 287–295.

    Article  PubMed  CAS  Google Scholar 

  19. Landesberg, R., Woo, V., Huang, L., et al. (2008). The expression of the receptor for glycation endproducts (RAGE) in oral squamous cell carcinomas. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics, 105, 617–624.

    Article  Google Scholar 

  20. Kong, J. P., Ding, F., Zhou, C. N., et al. (2004). Loss of myeloid-related proteins 8 and myeloid-related proteins 14 expression in human esophageal squamous cell carcinoma correlates with poor differentiation. World Journal of Gastroenterology, 10, 1093–1097.

    PubMed  CAS  Google Scholar 

  21. Sewell, D. A., Yuan, C. X., & Robertson, E. (2007). Proteomic signatures in laryngeal squamous cell carcinoma. Journal of Oto-Rhino-Laryngology and Its Related Specialties, 69, 77–84.

    Article  CAS  Google Scholar 

  22. He, Q. Y., Chen, J., Kung, H. F., et al. (2004). Identification of tumor-associated proteins in oral tongue squamous cell carcinoma by proteomics. Proteomics, 4, 271–278.

    Article  PubMed  CAS  Google Scholar 

  23. Arai, K., Teratani, T., Nozawa, R., et al. (2001). Immunohistochemical investigation of S100A9 expression in pulmonary adenocarcinoma: S100A9 expression is associated with tumor differentiation. Oncology Reports, 8, 591–596.

    PubMed  CAS  Google Scholar 

  24. Ghavami, S., Rashedi, I., Dattilo, B. M., et al. (2008). S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway. Journal of Leukocyte Biology, 83, 1484–1492.

    Article  PubMed  CAS  Google Scholar 

  25. Gebhardt, C., Riehl, A., Durchdewald, M., et al. (2008). RAGE signaling sustains inflammation and promotes tumor development. Journal of Experimental Medicine, 205, 275–285.

    Article  PubMed  CAS  Google Scholar 

  26. Garg, A. K., Jhingran, A., Klopp, A. H., et al. (2010). Expression of nuclear transcription factor kappa B in locally advanced human cervical cancer treated with definitive chemoradiation. International Journal of Radiation Oncology Biology Physics, 78, 1331–1336.

    Article  CAS  Google Scholar 

  27. Sheikh, A. A., Vimalachandran, D., Thompson, C. C., et al. (2007). The expression of S100A8 in pancreatic cancer-associated monocytes is associated with the Smad4 status of pancreatic cancer cells. Proteomics, 7, 1929–1940.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study was supported by the Special Foundation for Outstanding Young Scientists of Zhejiang Province, China (Grant No. 2009QN023), and a grant of science and technology project in Wenzhou (No. Y20080153).

Conflict of interest

All the authors declare no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xueqiong Zhu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhu, X., Jin, L., Zou, S. et al. Immunohistochemical Expression of RAGE and Its Ligand (S100A9) in Cervical Lesions. Cell Biochem Biophys 66, 843–850 (2013). https://doi.org/10.1007/s12013-013-9515-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12013-013-9515-x

Keywords

Navigation